Initial clinical experience with the new EBI (BARD-XT) flexible coronary stent: Acute results and follow-up

Sievert, Horst; Rohde, Stephan; Ensslen, R; Fach, Andreas; Merle, H; Schräder, Rainer; Spies, Hans

doi:10.1002/(sici)1097-0304(199802)43:2<159::aid-ccd10>3.0.co;2-j

Cited by 5 publications

(4 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Despite this, there were very few adverse clinical events. These findings compare favorably with those of randomized trials of stent implantation in highly selected patient and lesion groups and registry data [2][3][4][5][6][7][8][9][10][11]. The use of stents during coronary interventional procedures has increased dramatically over the 6 years since the Benestent and STRESS trials demonstrated reduced restenosis rates with stent deployment compared with angioplasty for focal de novo coronary artery lesions [2,3].…”

Section: Discussionsupporting

confidence: 53%

“…This has been particularly apparent over the last 6 years, exemplified by our unit where stents were used in only 13% of procedures in 1992 compared to over 80% in 1998. A major reason for their increased usage is the availability of newer designs that have overcome the limitations of earlier generation stents [5][6][7][8][9][10][11]. This article describes our initial clinical experience obtained in a consecutive series of patients with a full spectrum of coronary lesions undergoing V-Flex Plus stent deployment.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Preliminary experience with the V-Flex Plus coronary stent: Immediate and one-month clinical outcome

Rhydwen

Webster

Ruygrok

et al. 1999

Cathet. Cardiovasc. Intervent.

View full text Add to dashboard Cite

Procedural and 1‐month outcome data following implantation of the V‐Flex Plus stent in our first 54 consecutive patients (35 male; mean age, 62 years) are described. Sixty‐four stents were implanted for 60 mainly complex lesions; 48% were left anterior descending; 20%, circumflex; 27%, right coronary artery; and 5%, saphenous vein graft. The indication for stenting was elective in half of the patients and for a suboptimal result or as a bailout procedure in the other half. The stents were deployed at a mean of 12 atm (range, 6–18) and postdilated to a mean of 15 atm (range, 8–20). Pre‐ and postdilatation balloon sizes were 2.96 ± 0.57 mm and 3.16 ± 0.34 mm, respectively. The procedural success rate was 98%. There were no deaths or Q‐wave myocardial infarctions. One patient suffered a non–Q‐wave myocardial infarction and another developed a femoral false aneurysm. At 1‐month follow‐up, there were no additional events, in particular no revascularization procedures. Eighty‐nine percent of patients were free of angina. Implantation of the V‐Flex Plus stent is safe and effective with an excellent early success rate comparable to that of published randomized trials and registries of carefully selected patients. Cathet. Cardiovasc. Intervent. 47:504–508, 1999. © 1999 Wiley‐Liss, Inc.

show abstract

Section: Discussionsupporting

confidence: 53%

Section: Introductionmentioning

confidence: 99%

Preliminary experience with the V-Flex Plus coronary stent: Immediate and one-month clinical outcome

Rhydwen

Webster

Ruygrok

et al. 1999

Cathet. Cardiovasc. Intervent.

View full text Add to dashboard Cite

show abstract

“…1) [26,27]. The main branch proximal module and the distal branch modules are connected by longitudinal spines running from the main branch to each distal branch.…”

Section: Bard Xt Bifurcated Stentmentioning

confidence: 99%

Stenting with a true bifurcated stent: acute and mid-term follow-up results

Carlier

Giessen

Foley

et al. 1999

Cathet. Cardiovasc. Intervent.

View full text Add to dashboard Cite

“…Kissing balloon dilation was performed with a Bard Calypso balloon 3.50 mm for the LAD and 2.75 mm for the DIAG branch, both inflated at 8 atm. The stent is a modification of the BARD-XT [5][6][7], a balloon-expandable stent composed of multiple 2.15-mm-long modules consisting of zigzag rings welded to a longitudinal flexible spine. The Carina bifurcate stent is comprised of a main branch module, with two flexible spines and longer zigzag rings to allow expansion to diameters as large as 5.5 mm, and two side-branch modules, joined laterally to one of the two spines, allowing expansion up to 4.0 mm.…”

Section: Case Reportmentioning

confidence: 99%

Successful treatment of a bifurcation lesion with the Carina Bard stent: A case report

Colombo

Airoldi

Sheiban

et al. 1999

Cathet. Cardiovasc. Intervent.

View full text Add to dashboard Cite

In the last years new techniques and user‐friendly stents have improved the results of stent implantation in coronary bifurcational lesions but difficulties in stent deployment and incomplete coverage of the bifurcation remain a problem. We describe the case of a proximal lesion of the anterior descending artery involving a large diagonal branch treated with the Carina Bard bifurcate stent, a new device that allows the complete immediate coverage of a bifurcational lesion with a single stent. Cathet. Cardiovasc. Intervent. 48:89–92, 1999. © 1999 Wiley‐Liss, Inc.

show abstract

Initial clinical experience with the new EBI (BARD-XT) flexible coronary stent: Acute results and follow-up

Cited by 5 publications

References 12 publications

Preliminary experience with the V-Flex Plus coronary stent: Immediate and one-month clinical outcome

Preliminary experience with the V-Flex Plus coronary stent: Immediate and one-month clinical outcome

Stenting with a true bifurcated stent: acute and mid-term follow-up results

Successful treatment of a bifurcation lesion with the Carina Bard stent: A case report

Contact Info

Product

Resources

About